Publications by authors named "Pascal Lebray"

Claim this Profile
N
Non-invasive assessment of severe liver fibrosis in patients with Fontan-associated liver disease: The VALDIG-EASL FONLIVER cohort.
Luis Téllez, Diego Rincón, Audrey Payancé, Anaïs Jaillais, Pascal Lebray

J Hepatol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of the effects of pre-exposure treatment with hydroxychloroquine on the risk of COVID-19 infection and on the efficacy of anti-COVID-19 vaccination during lupus or Gougerot-Sjögren's disease: Prepcov multicentre trial.
Laurent Alric, Clara Brusq, Marion Migueres, Stephanie Faure, Pascal Lebray

Lupus Sci Med· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association between direct acting agents used for chronic hepatitis C virus infection and the occurrence of acute leukaemia - A disproportionality analysis.
Carole Scheifer, Bénédicte Lebrun-Vignes, Pascal Lebray, Florence Tubach, Agnès Dechartres

Clin Res Hepatol Gastroenterol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Utility of a score-based approach to liver assessment in heart transplant candidates.
Joshua A Rushakoff, Louie Cao, Joe Ebinger, Alexander Kuo, Patrick Botting, Pascal Lebray

JHLT Open· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Difficulties in assessing portal hypertension in case of HVB-HVD co infection.
Manon Allaire, Charles Roux, Sepideh Akhavan, Pascal Lebray, Dominique Thabut

Clin Res Hepatol Gastroenterol· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical and genetic definition of serum bilirubin levels for the diagnosis of Gilbert syndrome and hypobilirubinemia.
Thierry Poynard, Olivier Deckmyn, Valentina Peta, Mehdi Sakka, Pascal Lebray

Hepatol Commun· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnosis and management of hepatic encephalopathy: The French recommendations.
Dominique Thabut, Charlotte Bouzbib, Lucy Meunier, Manon Haas, Nicolas Weiss, Pascal Lebray

Liver Int· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Economic Impact of European Liver and Intestine Transplantation Association (ELITA) Recommendations for Hepatitis B Prophylaxis After Liver Transplantation.
Paolo Angelo Cortesi, Raffaella Viganò, Sara Conti, Ilaria Lenci, Riccardo Volpes, Pascal Lebray

Transpl Int· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patients Treated for HCV Infection and Listed for Liver Transplantation in a French Multicenter Study: What Happens at Five Years?
Lucy Meunier, Mohamed Belkacemi, George Philippe Pageaux, Sylvie Radenne, Anaïs Vallet-Pichard, Pascal Lebray

Viruses· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HCV eradication does not protect from fibrosis progression in patients with fibrosing cholestatic hepatitis after liver transplantation.
Audrey Coilly, Mylène Sebagh, Claire Fougerou-Leurent, Georges-Philippe Pageaux, Vincent Leroy, Pascal Lebray

Clin Res Hepatol Gastroenterol· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acute myeloid leukaemia following direct acting antiviral drugs in HCV-infected patients: A 10 years' retrospective single-center study.
Carole Scheifer, Elena Luckina, Bénédicte Lebrun-Vignes, Abdoul-Aziz Diop, Dominique Damais-Thabut, Pascal Lebray

Clin Res Hepatol Gastroenterol· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
"
"De novo" cholangiocarcinoma 20 years after liver transplantation for primary sclerosing cholangitis: Lifelong screening needed!
Pauline Bourdeleau, Edouard Larrey, Manon Allaire, Frederic Charlotte, Jean Christophe Vaillant, Pascal Lebray

Clin Res Hepatol Gastroenterol· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
2
2020 position statement and recommendations of the European Liver and Intestine Transplantation Association (ELITA): management of hepatitis B virus-related infection before and after liver transplantation.
Christophe Duvoux, Luca S Belli, James Fung, Mario Angelico, Maria Buti, Pascal Lebray

Aliment Pharmacol Ther· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply to: "Combined heart-liver transplantation for congestive hepatopathy with bridging fibrosis: Is it warranted?".
Manon Allaire, Anna Sessa, Jean François Cadranel, Pascal Lebray

JHEP Rep· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk factors of de novo malignancies after liver transplantation: a French national study on 11004 adult patients.
Mario Altieri, Olivier Sérée, Thierry Lobbedez, Philippe Segol, Armand Abergel, Pascal Lebray

Clin Res Hepatol Gastroenterol· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
From congestive hepatopathy to hepatocellular carcinoma, how can we improve patient management?
Anna Sessa, Manon Allaire, Pascal Lebray, Mourad Medmoun, Alberto Tiritilli

JHEP Rep· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Ribavirin for Hepatitis E Virus Infection After Organ Transplantation: A Large European Retrospective Multicenter Study.
Nassim Kamar, Florence Abravanel, Patrick Behrendt, Jörg Hofmann, Georges Phillippe Pageaux, Pascal Lebray

Clin Infect Dis· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical validation of the FLIP algorithm and the SAF score in patients with non-alcoholic fatty liver disease.
Fabio Nascimbeni, Pierre Bedossa, Larysa Fedchuk, Raluca Pais, Frédéric Charlotte, Pascal Lebray

J Hepatol· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatitis B virus reactivation in transplant patients treated for hepatitis C recurrence: Prophylaxis makes the difference.
Lina Mouna, Emilie Rossignol, Mariagrazia Tateo, Audrey Coilly, Jean-Charles Duclos-Vallée, Pascal Lebray

J Hepatol· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combined heart and liver transplantation: State of knowledge and outlooks.
Pascal Lebray, Shaida Varnous

Clin Res Hepatol Gastroenterol· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
LCR1 and LCR2, two multi-analyte blood tests to assess liver cancer risk in patients without or with cirrhosis.
Thierry Poynard, Valentina Peta, Olivier Deckmyn, Mona Munteanu, Joseph Moussalli, Pascal Lebray

Aliment Pharmacol Ther· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evolution of platelet functions in cirrhotic patients undergoing liver transplantation: A prospective exploration over a month.
Daniel Eyraud, Ludovic Suner, Axelle Dupont, Christilla Bachelot-Loza, David M Smadja, Pascal Lebray

PLoS One· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Net emergence of substitutions at position 28 in NS5A of hepatitis C virus genotype 4 in patients failing direct-acting antivirals detected by next-generation sequencing.
Thuy Nguyen, Sepideh Akhavan, Fabienne Caby, Luminita Bonyhay, Lucile Larrouy, Pascal Lebray

Int J Antimicrob Agents· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term prognostic value of the FibroTest in patients with non-alcoholic fatty liver disease, compared to chronic hepatitis C, B, and alcoholic liver disease.
Mona Munteanu, Raluca Pais, Valentina Peta, Olivier Deckmyn, Joseph Moussalli, Pascal Lebray

Aliment Pharmacol Ther· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Longterm Risk of Solid Organ De Novo Malignancies After Liver Transplantation: A French National Study on 11,226 Patients.
Olivier Sérée, Mario Altieri, Elodie Guillaume, Rémy De Mil, Thierry Lobbedez, Pascal Lebray

Liver Transpl· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis